In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Helmholtz Association

Latest From Helmholtz Association

In Germany, A Seed Fund Helps Start-Ups Bloom

Medical Device BioPharmaceutical

CircuLite Inc.

More than 80% of the ventricular assist devices in development today use an open surgical approach. CircuLite Inc. is developing a completely interventional VAD. With its percutaneous device, the company aims to extend treatment to patients at an earlier stage of heart failure, thus halting--or perhaps reversing--disease progression.

Medical Device

Following Compass' Lead

Corporate venture investment programs like Guidant's Compass walk a thin line between traditional business development and traditional venture capital investing. Compass' goal is to help Guidant find new technology early that could eventually help one of Guidant's core business groups but still earn a return on investment in the event the technology ultimately proves of no value to the corporation.

Medical Device Strategy

Impella Cardiotechnik GmbH

Medical Devices. Guidant Corp. and Atlas Venture have formed Impella to bring to market a microaxial blood flow device designed to provide full circulatory support during coronary artery bypass surgery, and in cases of acute heart failure.

Medical Device
See All

Company Information

  • Industry
  • Academic and Research Institutions
  • Other Names / Subsidiaries
    • Helmholtz Zentrum München